Absolute stereostructures of new arborinane-type triterpenoids and inhibitors of nitric oxide production from Rubia yunnanensis

Journal of Natural Products

Volumn 66, Issue 5, 2003, Pages 638-645

  Morikawa, Toshio ^a   Tao, Jing ^a   Ando, Shin ^a   Matsuda, Hisashi ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ARBORINANE DERIVATIVE; GLYCOSIDE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; RUBIA YUNNANENSIS EXTRACT; RUBIANOL A; RUBIANOL B; RUBIANOL C; RUBIANOL D; RUBIANOL E; RUBIANOSIDE I; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ACTIVATION; CELL ASSAY; CHINESE HERB; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; HERBAL MEDICINE; INFRARED SPECTROSCOPY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHYSICAL CHEMISTRY; PLANT ROOT; PROTON NUCLEAR MAGNETIC RESONANCE; RUBIA YUNNANENSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; TECHNIQUE;

ALGORITHMS; DRUGS, CHINESE HERBAL; INHIBITORY CONCENTRATION 50; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MOLECULAR STRUCTURE; NITRIC OXIDE; PLANT ROOTS; PLANTS, MEDICINAL; RUBIACEAE; STEREOISOMERISM; TRITERPENES;

ANIMALIA; RUBIA;

EID: 0038188652     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np0205710     Document Type: Article

References (19)

1. Part 10 in our series Bioactive Constituents of Chinese Natural Medicines. (b) For part 9: see Tao, J.; Morikawa, T.; Toguchida, I.; Ando, S.; Matsuda, H.; Yoshikawa, M. Bioorg. Med. Chem. 2002, 10, 4005-4012.
2. Zou, C.; Hao, X.-J.; Chen, C.-X.; Zhou, J. Acta Bot. Yunnan. 1992, 14, 114.
3. Zou, C.; Hao, X.-J.; Chen, C.-X.; Zhou, J. Acta Bot. Yunnan. 1993, 15, 89-91.
4. Zou, C.; Hao, X.-J.; Chen, C.-X.; Zhou, J. Acta Bot. Yunnan. 1999, 21, 256-259.
5. Liou, M.-J.; Wu, T.-S. J. Nat. Prod. 2002, 65, 1283-1287.
6. Chen, Y.-Q.; Luo, Y.-R. Youji Huaxue 1991, 11, 523-524.
7. Liou, M.-J.; Wu, P.-L.; Wu, T.-S. Chem. Pharm. Bull. 2002, 50, 276-279.
8. Zou, C.; Hao, X.-J.; Zhou, J. Acta Bot. Yunnan. 1993, 15, 399-402.
9. Shen, X.-Y.; Wu, H.-M.; He, M.; Hao, X.-J.; Zhou, J. Acta Chem. Sin. 1996, 54, 1194-1199.
10. Morikawa, T.; Matsuda, H.; Toguchida, I.; Ueda, K.; Yoshikawa, M. J. Nat. Prod. 2002, 65, 1468-1474.
11. Itokawa, H.; Qiao, Y.-F.; Takeya, K. Chem. Pharm. Bull. 1990, 38, 1435-1437.
12. Mahato, S. B.; Kundu, A. P. Phytochemistry 1994, 37, 1517-1575.
13. Duh, C.-Y.; Phoebe, C. H., Jr.; Pezzuto, J. M.; Kinghorn, A. D.; Farnsworth, N. R. J. Nat. Prod. 1986, 49, 706-709.
14. Fonseca, S. F.; Campello, J. P.; Barata, L. E. S.; Rúveda, E. A. Phytochemistry 1978, 17, 499-502.
15. 13C NMR, MS) with commercial samples.
16. 1H COSY), distortionless enhancement by polarization transfer (DEPT), and heteronuclear multiple bond connectivity (HMBC) experiments.
17. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.
18. CS Chem 3D (ver. 5.0, Cambridge Soft Corporation, Cambridge, MA) was used to build and optimize the conformation of I using MOPAC (AM1) program (Figure 1).
19. Since the absolute stereostructures ofrubiarbonols A and F have not been described, this paper represents the first report of the absolute stereostructures of rubiarbonols A and F.